Novo Nordisk stops testing of Ozempic as kidney trial meets efficacy goals
HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people.
 HQ Team October 10, 2023: Compounded ketamine products used to treat psychiatric disorders, are not safe, may put patients at severe risk of.
HQ Team October 10, 2023: US and Chinese researchers have developed an artificial intelligence-based platform to predict earthquakes with 70% accuracy. The AI.
HQ Team October 10, 2023: Chongqing Zhifei Biological Products, the largest Chinese vaccine company by revenue, will buy shingles vaccines from GSK Plc.,.
by Dr K. Leelamoni October 10, 2023: I had a sense of annoyance when I opened the door to greet Boopathy, 39, who.
HQ Team October 9, 2023: The WHO has released new guidelines to aid nations in reforming legislation to end human rights abuses and.
HQ Team October 9, 2023: Egypt has been granted a âgold tierâ status by the WHO for providing 93% of those diagnosed with.
HQ Team October 9, 2023: Bristol Myers Squibb, one of the worldâs largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through.
HQ Team October 7, 2023: More than 43 million children have been displaced internally due to climate change during the five years leading.
HQ Team October 7, 2023: Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction,.